You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 17, Issue 20

October-2 2025 - 118 articles

Cover Story: The urokinase-type plasminogen activator receptor (uPAR) regulates extracellular proteolysis, cell adhesion, migration, and tissue remodeling. In cancer, uPAR is frequently overexpressed, where it promotes invasion, metastatic spread, angiogenesis, and reshaping of the tumor microenvironment through interactions with uPA, integrins, vitronectin, and EGFR signaling. uPAR also contributes to immune cell recruitment and macrophage polarization, supporting a pro-invasive and immunosuppressive tumor environment. Circulating suPAR reflects systemic inflammatory and disease activity states. Increasing insight into uPAR biology has led to diagnostic applications and emerging therapeutic strategies, including monoclonal antibodies, uPA-derived peptides, and small-molecule antagonists. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (118)

  • Article
  • Open Access
659 Views
13 Pages

Carbon Ion Radiotherapy for Retroperitoneal Sarcoma: A Single-Institution Study

  • Reiko Imai,
  • Tsukasa Yonemoto,
  • Nobuhito Araki,
  • Hirotoshi Takiyama,
  • Hiroaki Ikawa,
  • Shigeru Yamada and
  • Hitoshi Ishikawa

21 October 2025

Background/Objectives: Surgery remains the mainstay of treatment for retroperitoneal sarcoma (RPS); however, definitive therapeutic strategies for patients with insufficient surgical margins and unresectable disease owing to locally advanced RPS rema...

  • Article
  • Open Access
910 Views
18 Pages

A Priori Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Using Deep Features from Pre-Treatment MRI and CT

  • Deok Hyun Jang,
  • Laurentius O. Osapoetra,
  • Lakshmanan Sannachi,
  • Belinda Curpen,
  • Ana Pejović-Milić and
  • Gregory J. Czarnota

21 October 2025

Background: Response to neoadjuvant chemotherapy (NAC) is a key prognostic indicator in breast cancer, yet current assessment relies on postoperative pathology. This study investigated the use of deep features derived from pre-treatment MRI and CT sc...

  • Article
  • Open Access
477 Views
15 Pages

The Impact of Local Ablative Therapies as Bridging Treatment on Overall Survival Following Liver Transplantation in Patients with HCC

  • Laura Schwenk,
  • Felix Dondorf,
  • Oliver Rohland,
  • Aladdin Ali-Deeb,
  • Utz Settmacher and
  • Falk Rauchfuß

21 October 2025

Background: The use of neoadjuvant therapies in patients with hepatocellular carcinoma prior to liver transplantation has gained increasing popularity in recent years. To date, there are only limited data investigating the impact of neoadjuvant thera...

  • Article
  • Open Access
860 Views
15 Pages

The Effectiveness of ¡Salud!, por la Vida, an Educational Intervention to Increase Colorectal Cancer Screening in Puerto Rico

  • Josheili Llavona-Ortiz,
  • Maria E. Fernández,
  • Ileska M. Valencia-Torres,
  • Francisco J. Muñoz-Torres,
  • Marievelisse Soto-Salgado,
  • Yara Sánchez-Cabrera and
  • Vivian Colón-López

21 October 2025

Background/Objectives: Colorectal cancer (CRC) is the leading cancer-related death in Puerto Rico (PR). Yet CRC screening (CRCS) rates remain low. We developed ¡Salud!, por la Vida, an educational intervention aiming to increase CRCS among age-...

  • Review
  • Open Access
601 Views
10 Pages

21 October 2025

Lymphomas involving the central nervous system (CNS) have worse outcomes, including both primary and secondary CNS lymphomas, which are associated with poorer overall survival outcomes. The World Health Organization classifies CNS lymphoma as arising...

  • Article
  • Open Access
450 Views
10 Pages

Evaluation of a Novel Tapered Tip EUS-FNB Needle: A UK Multicentre Study

  • Darragh Storan,
  • John Leeds,
  • Arif Hussenbux,
  • Mohamed Elseragy,
  • Ruridh Allen,
  • Tareq El Menabawey,
  • Aaron McGowan,
  • Matthew T. Huggett,
  • Umair Kamran and
  • Bidour Awadelkarim
  • + 3 authors

21 October 2025

Introduction: A new core biopsy needle with a novel tapered stylet tip has been introduced for endoscopic ultrasound-guided fine needle biopsy (EUS-FNB). The tapered point stylet is purported to improve ease of puncture, leading to improved tissue ac...

  • Article
  • Open Access
697 Views
18 Pages

A Novel Allosteric Inhibitor Targeting IMPDH at Y233 Overcomes Resistance to Tyrosine Kinase Inhibitors in Lymphoma

  • Nagarajan Pattabiraman,
  • Cosimo Lobello,
  • David Rushmore,
  • Luca Mologni,
  • Mariusz Wasik and
  • Johnvesly Basappa

21 October 2025

Background/Objective: Oncogenic tyrosine kinases (TKs) such as ALK and SRC promote cancer progression, but their effects on metabolic enzymes are still not well understood. This study examines how TK signaling regulates inosine monophosphate dehydrog...

  • Article
  • Open Access
506 Views
19 Pages

Impact of Diagnostic Confidence, Perceived Difficulty, and Clinical Experience in Facial Melanoma Detection: Results from a European Multicentric Teledermoscopic Study

  • Alessandra Cartocci,
  • Alessio Luschi,
  • Sofia Lo Conte,
  • Elisa Cinotti,
  • Francesca Farnetani,
  • Aimilios Lallas,
  • John Paoli,
  • Caterina Longo,
  • Elvira Moscarella and
  • Danica Tiodorovic
  • + 13 authors

21 October 2025

Background: Diagnosing facial melanoma, specifically lentigo maligna (LM) and lentigo maligna melanoma (LMM), is a daily clinical challenge, particularly for small or traumatized lesions. LM and LMM are part of the broader group of atypical pigmented...

  • Review
  • Open Access
1,832 Views
26 Pages

21 October 2025

Background: Biopsy remains the gold standard for characterizing breast cancer, but it is invasive, costly, and may not fully capture tumor heterogeneity. Advances in artificial intelligence (AI) now allow for the extraction of biological and clinical...

  • Review
  • Open Access
1 Citations
1,482 Views
26 Pages

Exosomes in HPV-Associated Cancers: From Biomarkers to Engineered Therapeutics

  • Muharrem Okan Cakir,
  • Melis Selek,
  • Betul Yilmaz,
  • Mustafa Ozdogan and
  • G. Hossein Ashrafi

21 October 2025

Background/Objectives: Human papillomavirus (HPV) is the main causative agent of cervical cancer and contributes to a significant proportion of other anogenital and oropharyngeal malignancies. The need for better biomarkers and therapeutic approaches...

of 12

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694